Literature DB >> 7514569

The stop mutation R553X in the CFTR gene results in exon skipping.

J Hull1, S Shackleton, A Harris.   

Abstract

Stop or nonsense mutations are known to disrupt gene function in a number of different ways. We have studied the effects of the stop mutation R553X in exon 11 of the CFTR gene by analyzing mRNA extracted from nasal epithelial cells harvested from patients with cystic fibrosis. Four patients who were compound heterozygotes for the R553X mutation were studied. Ten non-CF control subjects were also studied. In all four patients, full-length CFTR mRNA was identified, but only a very small proportion of this was derived from the R553X allele. A smaller transcript, lacking exon 11, was also seen in the R553X patients but not in the controls. Most of this transcript was derived from the R553X allele. These results suggest that the R553X mutation results in skipping of the exon in which it is located.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7514569     DOI: 10.1006/geno.1994.1070

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  10 in total

1.  Exon skipping through the creation of a putative exonic splicing silencer as a consequence of the cystic fibrosis mutation R553X.

Authors:  Isabel Aznarez; Julian Zielenski; Johanna M Rommens; Benjamin J Blencowe; Lap-Chee Tsui
Journal:  J Med Genet       Date:  2007-05       Impact factor: 6.318

2.  Influence of intron length on alternative splicing of CD44.

Authors:  M V Bell; A E Cowper; M P Lefranc; J I Bell; G R Screaton
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

3.  Defects in RNA splicing and the consequence of shortened translational reading frames.

Authors:  L E Maquat
Journal:  Am J Hum Genet       Date:  1996-08       Impact factor: 11.025

4.  Nearby stop codons in exons of the neurofibromatosis type 1 gene are disparate splice effectors.

Authors:  S Hoffmeyer; P Nürnberg; H Ritter; R Fahsold; W Leistner; D Kaufmann; W Krone
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

5.  Disruption of the splicing enhancer sequence within exon 27 of the dystrophin gene by a nonsense mutation induces partial skipping of the exon and is responsible for Becker muscular dystrophy.

Authors:  N Shiga; Y Takeshima; H Sakamoto; K Inoue; Y Yokota; M Yokoyama; M Matsuo
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

6.  A spectrum of ABCC6 mutations is responsible for pseudoxanthoma elasticum.

Authors:  O Le Saux; K Beck; C Sachsinger; C Silvestri; C Treiber; H H Göring; E W Johnson; A De Paepe; F M Pope; I Pasquali-Ronchetti; L Bercovitch; A S Marais; D L Viljoen; S F Terry; C D Boyd
Journal:  Am J Hum Genet       Date:  2001-08-31       Impact factor: 11.025

Review 7.  The cystic fibrosis gene: a molecular genetic perspective.

Authors:  Lap-Chee Tsui; Ruslan Dorfman
Journal:  Cold Spring Harb Perspect Med       Date:  2013-02-01       Impact factor: 6.915

8.  A nonsense mutation in the erythrocyte band 3 gene associated with decreased mRNA accumulation in a kindred with dominant hereditary spherocytosis.

Authors:  P B Jenkins; G K Abou-Alfa; D Dhermy; E Bursaux; C Féo; A L Scarpa; S E Lux; M Garbarz; B G Forget; P G Gallagher
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

9.  Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences.

Authors:  S N Teraoka; M Telatar; S Becker-Catania; T Liang; S Onengüt; A Tolun; L Chessa; O Sanal; E Bernatowska; R A Gatti; P Concannon
Journal:  Am J Hum Genet       Date:  1999-06       Impact factor: 11.025

10.  Spontaneous rescue from cystic fibrosis in a mouse model.

Authors:  Nikoletta Charizopoulou; Martina Wilke; Martina Dorsch; Alice Bot; Huub Jorna; Silke Jansen; Frauke Stanke; Hans J Hedrich; Hugo R de Jonge; Burkhard Tümmler
Journal:  BMC Genet       Date:  2006-03-29       Impact factor: 2.797

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.